首页 | 本学科首页   官方微博 | 高级检索  
检索        

手术联合复方仙灵骨葆胶囊治疗非创伤性股骨头坏死头的疗效观察
引用本文:夏子麒,刘沛,张启栋,郭万首,王卫国.手术联合复方仙灵骨葆胶囊治疗非创伤性股骨头坏死头的疗效观察[J].世界中医药,2020,15(11):1593-1597,1602.
作者姓名:夏子麒  刘沛  张启栋  郭万首  王卫国
作者单位:北京中医药大学,北京,100029;中日友好医院,免疫炎性疾病北京市重点实验室,北京,100029
基金项目:国家自然科学基金项目(81703896);首都卫生发展科研专项(2016-2-4062);国家重点研发计划课题(2017YFC0108102)
摘    要:目的:观察头颈部开窗病灶清除打压植骨术联合口服复方仙灵骨葆胶囊治疗非创伤性股骨头坏死的疗效。方法:选取2017年9月至2018年3月中日友好医院住院诊治的非创伤性股骨头坏死患者46例(79髋)作为研究对象,按照回顾性资料分为观察组(n=20)和对照组(n=26)。观察组采用头颈部开窗病灶清除打压植骨术联合口服复方仙灵骨葆胶囊治疗,对照组仅行头颈部开窗病灶清除打压植骨术。随访12~20个月,临床疗效评价采用Harris髋关节评分(Harris Hip Score,HHS),手术前和随访的X线和CT资料行影像学评价。结果:HHS为优、良的髋关节分别为25髋和20髋,2组股骨头生存率分别为:75.0%和64.1%,分期为ARCOⅡb、Ⅱc髋关节的优良率分别为100%和77.8%,而ARCOⅢa期髋关节的优良率为26.9%(P<0.05)。观察组HHS、影像学表现优于对照组,2组比较差异有统计学意义(P<0.05)。结论:头颈部开窗病灶清除打压植骨术联合口服复方仙灵骨葆胶囊治疗非创伤性股骨头坏死,能促进坏死骨修复,提高临床疗效。

关 键 词:头颈部开窗病灶清除打压植骨术  复方仙灵骨葆胶囊  非创伤性股骨头坏死  疗效观察  Harris髋关节评分  股骨头生存率
收稿时间:2019/6/24 0:00:00

Efficacy Observation on Operation Combined with Compound Xianling Gubao Capsules in the Treatment of Non-traumatic Osteonecrosis of Femoral Head
XIA Ziqi,LIU Pei,ZHANG Qidong,GUO Wanshou,WANG Weiguo.Efficacy Observation on Operation Combined with Compound Xianling Gubao Capsules in the Treatment of Non-traumatic Osteonecrosis of Femoral Head[J].World Chinese Medicine,2020,15(11):1593-1597,1602.
Authors:XIA Ziqi  LIU Pei  ZHANG Qidong  GUO Wanshou  WANG Weiguo
Institution:1 Beijing University of Chinese Medicine, Beijing 100029, China; 2 China-Japan Friendship Hospital, Beijing Key Laboratory of Immune Inflammatory Diseases, Beijing 100029, China)
Abstract:Objective:To observe efficacy of impacted bone grafting through windowing at the femoral head-neck junction and focus debridement combine with Compound Xianling Gubao Capsules in the treatment of non-traumatic osteonecrosis of femoral head(NONFH).Methods:Radiological data of 46 patients(79 hips)with NONFH admitted in China-Japan Friendship Hospital between September 2017 and March 2018 were selected as study objects and retrospectively reviewed.Those treated with impacted bone grafting through windowing at the femoral head-neck junction and focus debridement combine with Compound Xianling Gubao Capsules were considered as observation group,while those only treated with impacted bone grafting through windowing at the femoral head-neck junction and focus debridement were considered as control group.The followed-up lasted for 12 months to 20 months.The clinical efficacy was evaluated by Harris Hip Score(HHS).Pre-operation and follow-up X-ray and CT data were used for radiological evaluation.Results:According to the HHS,excellent or good results were 25 hips and 20 hips,respectively.In the 2 groups,survival rates of femoral head were 75.0%and 64.1%,respectively.The survival rate of femoral head was 100.0%and 77.8%of ARCOⅡb andⅡc stage,and 26.9%of ARCOⅢa(P<0.05).Compared with the control group,the observation group had HHS and radiological results,with statistically significant difference(P<0.05).Conclusion:Impacted bone grafting through windowing at the femoral head-neck junction and focus debridement combined with Compound Xianling Gubao Capsules can promote the repair of necrotic bone and improve the clinical efficacy in the treatment of NONFH.
Keywords:Impacted bone grafting through windowing at the femoral head-neck junction and focus debridement  Compound Xianling Gubao Capsules  Non-traumatic osteonecrosis of femoral head  Curative effect observation  Harris hip score  The femoral Head of survival
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《世界中医药》浏览原始摘要信息
点击此处可从《世界中医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号